MKP: Explanation for business result in QII-2011

Mekophar Chemical Pharmaceutical JSC (HOSE: MKP) explained the 13.8 percent increase in profit after tax of QII-2011 compared to QII-2010:

Although material prices and other expenses have increased, the Company tried to raised revenue of QII-2011 by 26.7% compared to QII-2010, mainly thanks to:

- Revenue from finished product: Up 12%

- Revenue from goods: Up 15%

- Revenue from materials and services: Up 0.3%

Besides, the Company also saved expenses in business operations, so that made profit in QII-2011 increase.

HOSE

>   GTA: Explanation for increase of profit in QII-2011 (08/08/2011)

>   SBA: Explanation for business result in QII-2011 (06/08/2011)

>   PHR: BOD Resolution No.4 (06/08/2011)

>   BSI: Resolution of Extraordinary Shareholders’ Meeting 2011 (06/08/2011)

>   DCL: Late submission of FS report & annual report (Time 3rd) (06/08/2011)

>   PXS: The BOD’s resolution (08/08/2011)

>   DIC: Explanation for business result in QII-2011 (06/08/2011)

>   SDT: Board Resolution (04/08/2011)

>   BT6: QII-2011 Financial Statements submission extension (04/08/2011)

>   DRH: Explanation for business result in quarter 2.2011 (04/08/2011)